仪器网
产品库
CB1-IN-1 is a peripherally restricted CB1R antagonist, with Ki of 0.3 nM and 21 nM for CB1R (EC50 = 3 nM) and CB2R, respectively.
CB1-IN-1 is a peripherally restricted CB1R antagonist, with Ki of 0.3 nM and 21 nM for CB1R (EC50 = 3 nM) and CB2R, respectively.
JD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM.
Benserazide hydrochloride, peripherally acting DOPA decarboxylase inhibitor盐酸苄丝肼, 外周性DOPA脱羧酶YZ剂
ABT-639 is a novel, peripherally acting, selective T-type Ca2+ channel blocker.
Naloxegol is a CYP3A4 enzyme inhibitor, is a peripherally-selective opioid antagonist, for the treatment of opioid-induced constipation.
Naloxegol oxalate is a CYP3A4 enzyme inhibitor, is a peripherally-selective opioid antagonist, for the treatment of opioid-induced constipation.
CB1R拮抗剂（CB1-IN-1）(1429239-98-4)(98.0%)
CB1R拮抗剂(JD-5037)(1392116-14-1)(98.0%)
Rat CB1R/CNR1(Cannabinoid receptor 1) ELISA Kit
CB1R拮抗剂(JD-5037)(1392116-14-1)
CB1R拮抗剂（CB1-IN-1）
CB1R拮抗剂(JD-5037)
本产品信息由（厦门慧嘉生物科技有限公司）为您提供，内容包括（CB1-IN-1 is a peripherally restricted CB1R antagonist, with Ki of 0.3 nM and 21 nM for CB1R (EC50 = 3 nM) and CB2R, respectively.）的品牌、型号、技术参数、详细介绍等；如果您想了解更多关于（CB1-IN-1 is a peripherally restricted CB1R antagonist, with Ki of 0.3 nM and 21 nM for CB1R (EC50 = 3 nM) and CB2R, respectively.）的信息，请直接联系供应商，给供应商留言。若当前页面内容侵犯到您的权益，请及时告知我们，我们将马上修改或删除。
沪公网安备 31011502008050号
